Access administrative, healthcare utilization and financial data.

Engage directly with influential stakeholders to address business challenges.

Improve patient outcomes, reduce waste and safely lower healthcare costs.

Integrate evidence-based practices, interventions and policies to help improve outcomes and the quality of care.

Accelerate care alignment with evidence-based guidelines and best practices.

Benefit from continuous, diverse educational offerings, including meetings, webinars, workshops, newsletters and customized education.

At every level of leadership, Premier’s experts are driving healthcare forward.

Meet our team of highly talented principals.

Research is at the core of our business. Learn more about the team here.

Discover what leading healthcare providers are achieving through Premier membership.

Stay informed with our white papers, webinars and e-books.

Browse our blog for a taste of what’s new and what’s next in healthcare.

Premier’s perspectives have been solicited by nationally renowned publications. Read on.

Read Premier’s latest announcements.

Headshot of 
    Gui Lopes

Gui Lopes

Ph.D., M.S.
Principal Research Scientist

Dr. Gui Lopes is a Principal Research Scientist for PINC AI™ Applied Sciences.

Dr. Lopes specializes in applied epidemiologic methods and advanced biostatistics techniques in areas such as pharmacogenomics, cardiovascular disease, cancer, and infectious diseases. He has substantial experience with electronic medical records, chart reviews, laboratory databases, pharmacogenomic databases, prospective data collection, and hospital administrative databases.

Prior to joining Premier, Dr. Lopes worked as a research associate in one of the largest nonprofit academic medical centers in the United States. Over the years, Dr. Lopes was the principal investigator of multiple retrospective research studies, was an invited speaker of international symposiums, and received multiple academic awards, including a NIH T32.

In addition, Dr. Lopes was at the forefront of an international collaboration (15+ countries) that developed a novel statistical method to detect complex patterns of toxicity in cancer clinical trials. During the COVID-19 pandemic, he also collaborated with city, county, and state healthcare officers by overseeing weekly reports of COVID-19 incidence in southwest Minnesota.

Dr. Lopes has published 40+ studies in peer-reviewed journals.

Dr. Lopes earned his B.S. (Psychology and Community Healthcare, 2012) and M.S. (Psychometrics and Correctional Health, 2014) at the Federal University of Ceará (Brazil). He earned his Ph.D. (Psychometrics and Women’s Health, 2018) at Oakland University (United States).

Featured Publications

Lopes G.S., Manemann S.M., Weston S.A. et al. Minnesota COVID-19 Lockdowns: The Effect on Acute Myocardial Infarctions and Revascularizations in the Community. Mayo Clinic Proceedings: Innovations, Quality & Outcomes. (2022).

Lopes, G.S., Lopes, J.L., Bielinski, S.J. et al. Identification of sex-specific genetic associations in response to opioid analgesics in a White, non-Hispanic cohort from Southeast Minnesota. The Pharmacogenomics Journal. (2022).

Lopes G.S., Tournigand C., Olswold C.L. et al. Adverse event load, onset, and maximum grade: A novel method of reporting adverse events in cancer clinical trials. Clinical Trials. (2021).


  • Ph.D., Psychometrics and Women’s Health, Oakland University
  • M.S., Psychometrics and Correctional Health, Federal University of Ceará, Brazil
  • B.S., Psychology and Community Healthcare, Federal University of Ceará, Brazil

More from the Research Team

View Leadership View Principals

Meet our experts and put our best-in-class, HIPAA-compliant database to work for you.

As your leading research and analytics partner, PINC AI™ Applied Sciences can help your organization improve the overall quality, safety and cost-effectiveness of care.